1,924
Views
163
CrossRef citations to date
0
Altmetric
Original Article

Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference

, , &
Pages 2487-2494 | Accepted 07 Jul 2009, Published online: 19 Aug 2009

References

  • Ohayon MM. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med Rev 2002;6:97-111
  • Leger D, Poursain B. An international survey of insomnia: under-recognition and undertreatment of a polysymptomatic condition. Curr Med Res Opin 2005;21:1785-92
  • Morin CM, LeBlanc M, Daley M, et al. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123-30
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
  • Hatoum HT, Kong SX, Kania CM, et al. Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organization enrollees. Pharmacoeconomics 1998;14:629-37
  • LeBlanc M, Beaulieu-Bonneau S, Merette C, et al. Psychological and health-related quality of life factors associated with insomnia in a population-based sample. J Psychosom Res 2007;63:157-66
  • Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154:1417-23
  • Leger D, Scheuermaier K, Philip P, et al. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001;63:49-55
  • Buysse DJ, ncoli-Israel S, Edinger JD, et al. Recommendations for a standard research assessment of insomnia. Sleep 2006;29:1155-73
  • Moul DE, Hall M, Pilkonis PA, et al. Self-report measures of insomnia in adults: rationales, choices, and needs. Sleep Med Rev 2004;8:177-98
  • Devine EB, Hakim Z, Green J. A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults. Pharmacoeconomics 2005;23:889-912
  • Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307
  • Morin CM. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev 2003;7:263-79
  • Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999;281:991-9
  • Savard MH, Savard J, Simard S, et al. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology 2005;14:429-41
  • Beaton DE, Bombardier C, Katz JN, et al. Looking for important change/differences in studies of responsiveness. J Rheumatol 2001;28:400-5
  • de Vet HC, Ostelo RW, Terwee CB, et al. Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Qual Life Res 2007;16:131-42
  • Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15
  • NIH. National Institutes of Health State of the Science Conference Statement on manifestations and management of chronic insomnia in adults. Sleep 2005;28:1049-57
  • Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: Effect on sleep, quality of life, and work limitations. Sleep 2007;30:959-68
  • Morgan K, Dixon S, Mathers N, et al. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technol Assess 2004;8:iii-68
  • Schubert CR, Cruickshanks KJ, Dalton DS, et al. Prevalence of sleep problems and quality of life in an older population. Sleep 2002;25:889-93
  • Ware JE, Kosinski M. SF-36 Physical & Mental Health Summary Scales: A Manual for Users of Version 1. 2nd edn. Lincoln, RI: QualityMetric Incorporated, 2001
  • Fichten CS, Creti L, Amsel R, et al. Poor sleepers who do not complain of insomnia: myths and realities about psychological and lifestyle characteristics of older good and poor sleepers. J Behav Med 1995;18:189-223
  • Stepanski E, Koshorek G, Zorick F, et al. Characteristics of individuals who do or do not seek treatment for chronic insomnia. Psychosomatics 1989;30:421-7
  • Lichstein KL, Means MK, Noe SL, et al. Fatigue and sleep disorders. Behav Res Ther 1997;35:733-40
  • Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 2000;14:275-90
  • Shapiro CM, Kayumov L. Sleepiness, fatigue, and impaired alertness. Semin Clin Neuropsychiatry 2000;5:2-5
  • Theobald DE. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone 2004;6(Suppl 1D):S15-21
  • Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3
  • Lichstein KL, Wilson NM, Noe SL, et al. Daytime sleepiness in insomnia: behavioral, biological and subjective indices. Sleep 1994;17:693-702
  • Bakshi R, Miletich RS, Henschel K, et al. Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology 1999;53:1151-3
  • Bakshi R, Shaikh ZA, Miletich RS, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000;6:181-5
  • Kos D, Nagels G, D'Hooghe MB, et al. A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurol 2006;6:27
  • Leger D, Guilleminault C, Bader G, et al. Medical and socio-professional impact of insomnia. Sleep 2002;25:625-9
  • Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22(Suppl 2):S386-93
  • Metlaine A, Leger D, Choudat D. Socioeconomic impact of insomnia in working populations. Ind Health 2005;43:11-19
  • Lerner D, Amick BC III, Rogers WH, et al. The Work Limitations Questionnaire. Med Care 2001;39:72-85
  • Lerner D, Reed JI, Massarotti E, et al. The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis. J Clin Epidemiol 2002;55:197-208
  • Amick BC III, Lerner D, Rogers WH, et al. A review of health-related work outcome measures and their uses, and recommended measures. Spine 2000;25:3152-60
  • Walker N, Michaud K, Wolfe F. Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients. J Rheumatol 2005;32:1006-12
  • Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 2000;18:419-23
  • Norman GR, Sridhar FG, Guyatt GH, et al. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 2001;39:1039-47
  • Eton DT, Cella D, Yost KJ, et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 2004;57:898-910
  • Hays RD, Farivar SS, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD 2005;2:63-7
  • Wyrwich KW, Nienaber NA, Tierney WM, et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999;37:469-78
  • Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999;52:861-73
  • Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102-9
  • Wyrwich KW, Metz SM, Kroenke K, et al. Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease. Health Serv Res 2007;42:2257-74; discussion 2294-323
  • Ware JE, Kosinski M, Bjorner JB, et al. User's Manual for the SF-36v2 Health Survey, 2nd edn. Lincoln, RI: QualityMetric Incorporated, 2007
  • Bjorner JB, Wallenstein GV, Martin MC, et al. Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin 2007;23:731-9
  • Steiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford: Oxford University Press, 1989
  • Erman MK. Sleep architecture and its relationship to insomnia. J Clin Psychiatry 2001;62(Suppl 10):9-17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.